Evidence map›Paper›PMID 37216590›Full record

ArticleNucleic acids research2023

The AnnotSV webserver in 2023: updated visualization and ranking.

Véronique Geoffroy, Jean-Baptiste Lamouche, Thomas Guignard, Samuel Nicaise, Arnaud Kress, Sophie Scheidecker, Antony Le Béchec, Jean Muller

Abstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Human reproduction open · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. REEV: review, evaluate and explain variants.Nucleic acids research · 2024
    Article
  16. Dual diagnosis ofRare (Amsterdam, Netherlands) · 2024
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Véronique GeoffroyUniversité de Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.
Jean-Baptiste LamoucheLaboratoire de Génétique Médicale, UMR 1112, INSERM, IGMA, Université de Strasbourg, Strasbourg, France.
Thomas GuignardUnité de Génétique Chromosomique, CHU Montpellier, France.
Samuel NicaiseUnité Fonctionnelle de Bioinformatique Médicale appliquée au diagnostic (UF7363), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Arnaud KressComplex Systems and Translational Bioinformatics, ICube, UMR 7357, University of Strasbourg, CNRS, FMTS, Strasbourg, France.
Sophie ScheideckerLaboratoire de Génétique Médicale, UMR 1112, INSERM, IGMA, Université de Strasbourg, Strasbourg, France.
Antony Le BéchecUnité Fonctionnelle de Bioinformatique Médicale appliquée au diagnostic (UF7363), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Jean MullerLaboratoire de Génétique Médicale, UMR 1112, INSERM, IGMA, Université de Strasbourg, Strasbourg, France.ORCID 0000-0002-7682-559X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Much of the human genetics variant repertoire is composed of single nucleotide variants (SNV) and small insertion/deletions (indel) but structural variants (SV) remain a major part of our modified DNA. SV detection has often been a complex question to answer either because of the necessity to use different technologies (array CGH, SNP array, Karyotype, Optical Genome Mapping…) to detect each category of SV or to get an appropriate resolution (Whole Genome Sequencing). Thanks to the deluge of pangenomic analysis, Human geneticists are accumulating SV and their interpretation remains time consuming and challenging. The AnnotSV webserver (https://www.lbgi.fr/AnnotSV/) aims at being an efficient tool to (i) annotate and interpret SV potential pathogenicity in the context of human diseases, (ii) recognize potential false positive variants from all the SV identified and (iii) visualize the patient variants repertoire. The most recent developments in the AnnotSV webserver are: (i) updated annotations sources and ranking, (ii) three novel output formats to allow diverse utilization (analysis, pipelines), as well as (iii) two novel user interfaces including an interactive circos view.

Indexed as

INDEL MutationPolymorphism, Single NucleotideSoftwareDiseaseGenome, HumanHigh-Throughput Nucleotide SequencingHumansRestriction MappingSequence Analysis, DNAWhole Genome Sequencing

Identifiers

PMID37216590
PMCPMC10320077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.